Surgical imaging developer Novadaq Technologies has acquired Aimago, the developer of a skin perfusion imaging device.
Aimago was founded in 2008 as a spin-off from Ecole Polytechnique Federale de Lausanne (EPFL), an academic and research institution in Switzerland. The company's EasyLDI perfusion camera uses full-field laser Doppler technology to acquire "point-and-shoot" perfusion imaging at the skin's surface for clinical applications such as wounds, burns, and limb ischemia.
The EasyLDI perfusion camera has both U.S. Food and Drug Administration 510(k) and CE Mark clearance, and the company has installed the first four commercial systems at sites in Europe. Novadaq believes the product complements its Spy technology, which provides deeper quantitative vascular and microcirculation blood flow and perfusion assessment for use during treatment in operating rooms and wound care clinics.
